Long‐term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy
Author:
Affiliation:
1. Chubu Rosai Hospital, Nagoya
2. Sportology Centre, Juntendo University Graduate School of Medicine, Tokyo
3. NTT West Osaka Hospital, Osaka
4. Shiga University of Medical Science, Otsu, Japan.
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1464-5491.2012.03684.x
Reference31 articles.
1. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2. Standards of Medical Care in Diabetes—2011
3. Mechanism of diabetic neuropathy: Where are we now and where to go?
4. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study
5. Vascular Risk Factors and Diabetic Neuropathy
Cited by 116 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Metabolomics and molecular dynamics unveil the therapeutic potential of epalrestat in diabetic nephropathy;International Immunopharmacology;2024-10
2. SMARCA5 reprograms AKR1B1-mediated fructose metabolism to control leukemogenesis;Developmental Cell;2024-08
3. Combination therapy is it in the future for successfully treating peripheral diabetic neuropathy?;Frontiers in Endocrinology;2024-05-15
4. An aldose reductase inhibitor, WJ-39, ameliorates renal tubular injury in diabetic nephropathy by activating PINK1/Parkin signaling;European Journal of Pharmacology;2024-03
5. Parallelism and non-parallelism in diabetic nephropathy and diabetic retinopathy;Frontiers in Endocrinology;2024-02-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3